Shares of Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report) fell 3.9% on Friday . The company traded as low as $10.46 and last traded at $10.36. 8,771 shares changed hands during mid-day trading, a ...
The House Oversight Committee is asking "tech leaders who have spoken publicly about debanking to share their stories." ...
Kevin Willsey, a JPMorgan Chase & Co. global chair of investment banking and capital markets, is retiring after more than ...
Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...
Some of the other senior executives at the bank also saw their compensation rising by between 4% and 21% in 2024.
JPMorgan Chase & Co. (NYSE:JPM) has disclosed that its independent board members have approved a rise in annual compensation for CEO James Dimon. For the year 2024, Mr. Dimon will receive $39 million, ...
JPMorgan Chase said Thursday that long-serving CEO Jamie Dimon’s 2024 pay package climbed about 8.3% to $39 million after the bank posted a record profit amid a revival in dealmaking and fundraising ...
JPMorgan Chase said on Thursday that long-serving CEO Jamie Dimon's 2024 pay package climbed about 8.3% to $39 million after ...
Jamie Dimon was awarded an 8.3% pay raise following a year of record profitability at JPMorgan and amid questions about who ...
(Reuters) - JPMorgan Chase said on Thursday CEO Jamie Dimon's 2024 compensation climbed about 8.3% to $39 million. The pay ...
Jamie Dimon praised Elon Musk as "our Einstein," resolving past legal disputes, while discussing JPMorgan's acquisition ...
At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...